Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani, D. A. Gabriel, J. L. Gajewski, David R Jacobs Jr, Daniel J Weisdorf, N. S. Key

Research output: Contribution to journalLetter

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)825-828
Number of pages4
JournalBone marrow transplantation
Volume38
Issue number12
DOIs
StatePublished - Dec 1 2006

Cite this